Derived from Latin, the notion “in vitro diagnostics” refers to tests such as blood, tissues, or urine tests that are carried out in controlled environment outside a living organism. In vitro diagnostics tests are usually held in a laboratory, while sometimes they are carried out at home. In vitro diagnostics is used in hematology, clinical chemistry, molecular diagnostics, immunology, etc.
Development of technologies, the growing incidence of respiratory, sexually transmitted diseases are among the top factors contributing to the market growth. In vitro diagnostics gains popularity worldwide and the market grows swiftly, especially in developing countries such as India and China. Alere Inc, Beckman Coulter Inc and Diasorin Diagnostic S.P.A. are amidst majors are active in the in vitro diagnostics market.
The Catalogue includes research reports offering cutting-edge data on the market for in vitro diagnostics. The reports provide analyses market’s drivers and restraints. The research studies contain profiles of leading market participants. Overviews of the competitive landscape and technologies are available in the reports too.
Publications found:
36,830
Sort by:
2016-2020 Future Horizons and Growth Strategies in the French HIV/AIDS Diagnostic Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 1,840.00
Complete report $2,300. DataPack (test volumes, sales forecasts, supplier shares) $1,500 Summary This report presents detailed analyses of the AIDS diagnostics market in France. The report provides test volume and sales forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, HTLV-I/II, Western Blot and other ...
March 2016
250 pages
2016-2020 Future Horizons and Growth Strategies in the Italian HIV/AIDS Diagnostic Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 1,840.00
Complete report $2,300. DataPack (test volumes, sales forecasts, supplier shares) $1,500 Summary This report presents detailed analyses of the AIDS diagnostics market in Italy. The report provides test volume and sales forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, HTLV-I/II, Western Blot and other confirmatory ...
March 2016
250 pages
2016-2020 Future Horizons and Growth Strategies in the Japanese HIV/AIDS Diagnostic Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 1,840.00
Complete report $2,300. DataPack (test volumes, sales forecasts, supplier shares) $1,500 Summary This report presents detailed analyses of the AIDS diagnostics market in Japan. The report provides test volume and sales forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, HTLV-I/II, Western Blot and other confirmatory ...
March 2016
250 pages
2016-2020 Future Horizons and Growth Strategies in the Spanish HIV/AIDS Diagnostic Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 1,840.00
Complete report $2,300. DataPack (test volumes, sales forecasts, supplier shares) $1,500 Summary This report presents detailed analyses of the AIDS diagnostics market in Spain. The report provides test volume and sales forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, HTLV-I/II, Western Blot and other confirmatory ...
March 2016
250 pages
2016-2020 Future Horizons and Growth Strategies in the UK HIV/AIDS Diagnostic Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 1,840.00
Complete report $2,300. DataPack (test volumes, sales forecasts, supplier shares) $1,500 Summary This report presents detailed analyses of the AIDS diagnostics market in the UK. The report provides test volume and sales forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, HTLV-I/II, Western Blot and other ...
March 2016
251 pages
2016-2020 Future Horizons and Growth Strategies in the US HIV/AIDS Diagnostic Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 1,840.00
Complete report $2,300. DataPack (test volumes, sales forecasts, supplier shares) $1,500 Summary This report presents detailed analyses of the AIDS diagnostics market in the US. The report provides test volume and sales forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, HTLV-I/II, Western Blot and other ...
March 2016
250 pages
2016-2020 Global Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US
US$ 27,800.00
... and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological ...
March 2016
1200 pages
2016-2020 Global Molecular Blood Typing, Grouping and Infectious Disease NAT Market: Instrument and Reagent Supplier Shares, Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US
US$ 28,400.00
... : Blood Centers Plasma Fractionation Facilities Hospitals Commercial/Private Laboratories Military Blood Banks Current and Emerging Products Analysis of current and emerging molecular blood typing, grouping and infectious disease NAT screening assays. Review of automated and semi-automated molecular and immunohematology analyzers ...
March 2016
775 pages
2016-2020 Future Horizons and Growth Strategies in the World Cancer Diagnostics Market: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities
US$ 27,800.00
... segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers by country. Cancer statistics, etiology and recent ... and emerging cancer diagnostic tests, including: Biochemical Markers Oncogenes Growth Factors Hormones Colony Stimulating Factors Lymphokines Immunohistochemical Stains, and ...
March 2016
1200 pages
2016-2020 Future Horizons and Growth Strategies in the European Clinical Chemistry and Immunodiagnostic Markets: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities
US$ 15,760.00
... Analysis Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers, by country. Test volume and sales forecasts ...
March 2016
900 pages
2016-2020 Future Horizons and Growth Strategies in the World Clinical Chemistry and Immunodiagnostic Markets: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities
US$ 30,000.00
... Analysis Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers, by country. Test volume and sales forecasts ...
March 2016
1200 pages
2016-2020 Future Horizons and Growth Strategies in the Global Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities
US$ 27,800.00
... segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers by country. Cancer statistics, etiology and recent ... current and emerging tumor markers, including:- Biochemical Markers - Oncogenes - Growth Factors - Hormones - Colony Stimulating Factors - Lymphokines - Immunohistochemical Stains, and ...
March 2016
1200 pages
2016-2020 World Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices-Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 27,600.00
... by country, section, market segment, and can be custom-tailored to your specific information needs and budget. “2016 World Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs ... ’s new study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends ...
March 2016
1200 pages
2016-2020 Agrochemicals: Energy Prices and Global Economy Eastward Shift Changing Success Formula—Fungicides, Herbicides, Insecticides
US$ 3,080.00
The companies analyzed in this report include ADAMA, BASF, Bayer, Dow, DuPont, FMC, Monsanto, Nufarm, Sumitomo, and Syngenta. For each company, the report provides: Specific business, new product development and marketing strategies. Strengths and weaknesses. Anticipated acquisitions, joint ventures and ...
March 2016
106 pages
